Hidetaka Masuda

Characterization of a cis-diamminedichloroplatinum(II)-resistant human ovarian cancer cell line and its use in evaluation of platinum analogues.

Brent C. Behrens, Thomas C. Hamilton, Hidetaka Masuda et al. · PubMed · 1987 · 500 citations

Chemoprevention Strategy, Oncogenic Agent, Medicine +12

Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines.

Hidetaka Masuda, R F Ozols, Gi‐Ming Lai et al. · PubMed · 1988 · 284 citations

Dna Damage, Molecular Biology, Cancer Biology +16

Cisplatin Generates Superoxide Anion by Interaction with DNA in a Cell-Free System

Hidetaka Masuda, Toshiko Tanaka, Umeo Takahama · Biochemical and Biophysical Research Communications · 1994 · 254 citations

Chromatin, Chromatin Remodeling, Natural Sciences +9

Increased removal of DNA-bound platinum in a human ovarian cancer cell line resistant to cis-diamminedichloroplatinum(II).

Hidetaka Masuda, Toshiko Tanaka, Haruo Matsuda et al. · PubMed · 1990 · 98 citations

Oocyte, Dna Analysis, Molecular Biology +20

Serum CEA levels facilitate detection of recurrences of cancer in patients after gastrectomy

R Tamada, Yoichiro Hiramoto, Shunichi Tsujitani et al. · Surgery Today · 1985 · 34 citations

Surgical Oncology, Gastrointestinal Oncology, Cancer Detection +6